Publikation

Prognosis in stage II melanoma of the head and neck depends on the histological subtype.

Wissenschaftlicher Artikel/Review - 23.07.2023

Bereiche
PubMed
DOI
Kontakt

Zitation
Jasper S, Keim U, Leiter U, Amaral T, Flatz L, Forschner A. Prognosis in stage II melanoma of the head and neck depends on the histological subtype. J Dtsch Dermatol Ges 2023; 21:1137-1146.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
J Dtsch Dermatol Ges 2023; 21
Veröffentlichungsdatum
23.07.2023
eISSN (Online)
1610-0387
Seiten
1137-1146
Kurzbeschreibung/Zielsetzung

The melanoma guideline is mainly based on the AJCC stage. There is no difference according to histological subtypes such as superficial spreading melanoma (SSM), lentigo maligna melanoma (LMM) or nodular malignant melanoma (NM). We aimed to evaluate whether patients with LMM have a different clinical course from patients with SSM/NM. This is particularly important as adjuvant anti-PD-1 therapy is approved for stage IIB and IIC melanoma.